Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity a phase 1 dosing study

David K. Wallace, Raymond T. Kraker, Sharon F. Freedman, Eric R. Crouch, Amy K. Hutchinson, Amit R. Bhatt, David L. Rogers, Michael B. Yang, Kathryn M. Haider, Deborah K. Van Der Veen, R. Michael Siatkowski, Trevano W. Dean, Roy W. Beck, Michael X. Repka, Lois E. Smith, William V. Good, Mary Elizabeth Hartnett, Lingkun Kong, Jonathan M. Holmes

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity a phase 1 dosing study'. Together they form a unique fingerprint.

Medicine & Life Sciences